Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
מצבים רפואיים
Metastatic Malignant Solid Neoplasm · Unresectable Malignant Solid Neoplasm
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
City of Hope Comprehensive Cancer Center, Duarte, California, United States
Contact: Principal Investigator (Sharonlin Bhardwaj)UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
Contact: Principal Investigator (Shumei Kato)Los Angeles General Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Varsha Tulpule)USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Varsha Tulpule)UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
UC San Diego Medical Center - Hillcrest, San Diego, California, United States
Contact: Principal Investigator (Shumei Kato)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Gini F. Fleming)National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States
Contact: Principal Investigator (A P. Chen)National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Gerburg M. Wulf)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Geoffrey I. Shapiro)NYU Langone Hospital - Long Island, Mineola, New York, United States
Contact: Principal Investigator (Nancy Chan)Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Principal Investigator (Nancy Chan)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (John L. Hays)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Debra L. Richardson)Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Vaia Florou)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Michael Schweizer)University of Washington Medical Center - Montlake, Seattle, Washington, United States
Contact: Principal Investigator (Michael Schweizer)University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
Contact: Principal Investigator (Jeremy Kratz)University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
מובילי המחקר
Geoffrey I Shapiro
Principal Investigator
Dana-Farber - Harvard Cancer Center LAO